THE IMPACT OF ADJUNCT DAPAGLIFLOZIN ON TREATMENT SATISFACTION IN TYPE 1 DIABETES MELLITUS

被引：0
|
作者：
Gordon, J. [1 ]
Beresford-Hulme, L. [1 ]
Bennett, H. [2 ]
Tank, A. [3 ]
Edmonds, C. [3 ]
McEwan, P. [2 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Birmingham, W Midlands, England
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales
[3] AstraZeneca, Cambridge, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB96
引用
收藏
页码：S590 / S590
页数：1
相关论文
共 50 条
  • [41] Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands
    Heleen G. M. van Haalen
    Marjolein Pompen
    Klas Bergenheim
    Phil McEwan
    Rebecca Townsend
    Marina Roudaut
    Clinical Drug Investigation, 2014, 34 : 135 - 146
  • [42] Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands
    van Haalen, Heleen G. M.
    Pompen, Marjolein
    Bergenheim, Klas
    McEwan, Phil
    Townsend, Rebecca
    Roudaut, Marina
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 135 - 146
  • [43] Comparison of the pharmacokinetics and pharmacodynamics of dapagliflozin in patients with type 1 versus type 2 diabetes mellitus
    Tang, W.
    Leil, T. A.
    Johnsson, E.
    Boulton, D. W.
    LaCreta, F.
    DIABETES OBESITY & METABOLISM, 2016, 18 (03): : 236 - 240
  • [44] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [45] Hypoglycemia frequency and treatment satisfaction in patients receiving insulin analogues for treatment of type 1 diabetes mellitus
    Berlanda, Gabriela
    Telo, Gabriela H.
    Krug, Barbara Correa
    Scheffel, Rafael Selbach
    Pasinato, Bruna
    Iorra, Fernando
    dos Reis, Joao Gabbardo
    Picon, Paulo Dornelles
    Schaan, Beatriz D.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (02): : 164 - 171
  • [46] Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus
    Calado, Joaquim
    IDRUGS, 2009, 12 (12) : 785 - 798
  • [47] Dapagliflozin: A Review in Type 1 Diabetes
    Paik, Julia
    Blair, Hannah A.
    DRUGS, 2019, 79 (17) : 1877 - 1884
  • [48] Dapagliflozin: A Review in Type 1 Diabetes
    Julia Paik
    Hannah A. Blair
    Drugs, 2019, 79 : 1877 - 1884
  • [49] Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
    Julia K. Mader
    Lene Jensen
    Steen H. Ingwersen
    Erik Christiansen
    Simon Heller
    Thomas R. Pieber
    Clinical Pharmacokinetics, 2016, 55 : 1457 - 1463
  • [50] Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
    Mader, Julia K.
    Jensen, Lene
    Ingwersen, Steen H.
    Christiansen, Erik
    Heller, Simon
    Pieber, Thomas R.
    CLINICAL PHARMACOKINETICS, 2016, 55 (11) : 1457 - 1463
12345